CORRECTION article

Front. Genet., 26 January 2024

Sec. Cancer Genetics and Oncogenomics

Volume 15 - 2024 | https://doi.org/10.3389/fgene.2024.1357409

Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer

  • 1. Department of Laboratory Medicine, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

  • 2. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen Cancer Center, Guanghzou, China

  • 3. Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou, China

  • 4. Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Article metrics

View details

1,1k

Views

503

Downloads

In the published article, there was an error in the Funding statement. The funding number for The Science and Technology Program of Guangzhou was incorrectly given as “2019-02-01-06-3001-0005”. The correct number is “201903010039”. The corrected Funding statement appears below.

Statements

Funding

“This project was supported by: The Science and Technology Program of Guangzhou (201903010039); R&D Plan of Key Areas in Guangdong Province (2019B020231001); Urban Area (High Tech Zone) Joint COVID-19 Infection Emergency Research Project (2020Q-P016).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

HAVCR1, prognosis, diagnostic, liver hepatocellular carcinoma, pancreatic adenocarcinoma

Citation

Liu S, Tang W, Cao J, Shang M, Hengchang S, Gong J and Hu B (2024) Corrigendum: A comprehensive analysis of HAVCR1 as a prognostic and diagnostic marker for pan-cancer. Front. Genet. 15:1357409. doi: 10.3389/fgene.2024.1357409

Received

18 December 2023

Accepted

15 January 2024

Published

26 January 2024

Volume

15 - 2024

Edited and reviewed by

Anton A. Buzdin, European Organisation for Research and Treatment of Cancer, Belgium

Updates

Copyright

*Correspondence: Bo Hu, ; Jiao Gong,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics